Literature DB >> 33773852

The relationship between nutrition and Ménière's disease.

Esma Oğuz1, Aybike Cebeci1, Cennet Reyyan Geçici2.   

Abstract

Ménière's disease is an inner ear disease with attacks characterized by ear fullness, tinnitus, fluctuant sensorineural hearing loss and vertigo. Although pathophysiology of the disease is not fully known, endolymphatic hydrops are believed to play a role. Although there is no certain treatment procedure for Ménière's disease, some treatments are applied to prevent attacks, to treat the symptoms that occur during the attacks, and to prevent the permanent effects of the symptoms on the hearing and balance system. Lifestyle changes, dietary modifications, diuretics, vasodilator corticosteroids, intratympanic steroids, surgical methods are some of these treatment methods. Dietary modification includes a low sodium diet, a reduction in daily alcohol and caffeine intake, a gluten-free diet, and a new dietary approach to specially processed grains, all of which are first-line treatments. The goal of this review article is to examine the relationship between MD and dietary intervention, which is frequently used in the prevention and treatment of MD attacks.
Copyright © 2021. Published by Elsevier B.V.

Entities:  

Keywords:  Allergy; Endolymphatic hydrops; Gluten free diet; Low sodium intake; Ménière's disease

Mesh:

Substances:

Year:  2021        PMID: 33773852     DOI: 10.1016/j.anl.2021.03.006

Source DB:  PubMed          Journal:  Auris Nasus Larynx        ISSN: 0385-8146            Impact factor:   1.863


  2 in total

1.  Hearing Benefits of Clinical Management for Meniere's Disease.

Authors:  Yi Zhang; Chenyi Wei; Zhengtao Sun; Yue Wu; Zhengli Chen; Bo Liu
Journal:  J Clin Med       Date:  2022-05-31       Impact factor: 4.964

2.  Smoking Is Positively Related and Alcohol Consumption Is Negatively Related to an Increased Risk of Meniere's Disease.

Authors:  So Young Kim; Juyong Chung; Dae Myoung Yoo; Mi Jung Kwon; Ji Hee Kim; Joo-Hee Kim; Heejin Kim; Hyo Geun Choi
Journal:  J Clin Med       Date:  2022-08-26       Impact factor: 4.964

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.